A) TEST is developed by Yonsei University.

What development phase is A) TEST in?

A) TEST is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

A) TEST

Yonsei University · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	A) TEST
Also known as	1. Test group : Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®)
Sponsor	Yonsei University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

A) TEST CI brief — competitive landscape report
A) TEST updates RSS · CI watch RSS
Yonsei University portfolio CI